Neurofibromatosis 2 tumor suppressor protein, merlin, forms two functionally important intramolecular associations

Journal of Neuroscience Research

Volumn 58, Issue 5, 1999, Pages 706-716

  Gutmann, David H ^a   Haipek, Carrie Ann ^a   Lu, Kimberly Hoang ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

ERM proteins; Protein 4.1 family; Schwannoma; Schwannomin

Indexed keywords

GENE PRODUCT; MERLIN;

AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; GENE MUTATION; NEURILEMOMA; NEUROFIBROMATOSIS; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN FAMILY; PROTEIN FOLDING; PROTEIN INTERACTION; TUMOR SUPPRESSOR GENE;

BLOTTING, WESTERN; DNA, COMPLEMENTARY; EXONS; HUMANS; MEMBRANE PROTEINS; MICROTUBULES; NEUROFIBROMATOSIS 2; NEUROFIBROMIN 2; PROTEIN STRUCTURE, TERTIARY;

EID: 0033485979     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4547(19991201)58:5<706::AID-JNR12>3.0.CO;2-Z     Document Type: Article

References (39)

1. Berryman M, Gary R, Bretscher A. 1995. Ezrin oligomers are major cytoskeletal components of placental microvilli: a proposal for their involvement in cortical morphogenesis. J Cell Biol 131: 1231-1242.
2. denBakker MA, Tacilar M, Reigman PHJ, Hekman ACP, Boersma W, Janssen PJA, deJong TAW, Hendriks Q, vanderKwast TH, Zwartoff E. 1995. Neurofibromatosis type 2 protein co-localizes with elements of the cytoskeleton. Am J Pathol 147:1339-1349.
3. Gary R, Bretscher A. 1993. Heterotypic and homotypic associations between ezrin and moesin, two putative membrane-cytoskeletal linking proteins. Proc Natl Acad Sci USA 90:10846-10850.
4. Gary R, Bretscher A. 1995. Ezrin self-association involves binding of an N-terminal domain to a normally masked C-terminal domain that includes the F-actin binding site. Mol Biol Cell 6:1061-1075.
5. Gonzalez-Agosti C, Xu L, Pinney D, Beauchamp R, Hobbs W, Gusella J, Ramesh V. 1996 The merlin tumor suppressor localizes preferentially in membrane ruffles. Oncogene 13:1239-1247.
6. Gutmann DH, Giordano MJ, Fishback AS, Guha A. 1997. Loss of merlin expression in sporadic meningiomas, ependymomas and schwannomas. Neurology 48:267-270.
7. Gutmann DH, Geist RT, Xu H-M, Kim JS, Saporito-Irwin S. 1998. Defects in neurofibromatosis 2 protein function can arise at multiple levels. Hum Molec Genet 7:335-345.
8. Gutmann DH, Sherman L, Seftor L, Haipek C, Lu KH, Hendrix M. 1999. Increased expression of the NF2 tumor suppressor gene product, merlin, impairs cell motility, adhesion and spreading. Hum Molec Genet 8:267-275.
9. Henry MD, Agosti CG, Solomon F. 1995. Molecular dissection of radixin: distinct and interdependent functions of the amino-and carboxy-terminal domains. J Cell Biol 129:1007-1022.
10. Hitotsumatsu T, Iwaki T, Kitamoto T, Mizoguchi M, Suzuki SO, Hamada Y, Fukui M, Tateishi J. 1997. Expression of neurofibromatosis 2 protein in human brain tumors: an immunohistochemical study. Acta Neuropathol 93:225-232.
11. Hirao M, Sato N, Kondo T, Yonemura S, Monden M, Sasaki T, Takai Y, Tsukita S, Tsukita S. 1996. Regulation mechanism of ERM (ezrin/radixin/moesin) protein/plasma membrane association: possible involvement of phosphatidylinositol turnover and Rho-dependent signaling pathway. J Cell Biol 135:37-51.
12. Huynh DP, Pulst S-M. 1996. Neurofibromatosis 2 antisense oligodeoxynucleotides induce reversible inhibition of schwannomin synthesis and cell adhesion in STS26T and T98G cells. Oncogene 13:73-84.
13. Huynh DP, Mautner V, Baser ME, Stavrou D, Pulst S-M. 1997. Immunohistochemical detection of schwannomin and neurofibromin in vestibular schwannomas, ependymomas, and meningiomas. J Neuropathol Exp Neurol 56:382-390.
14. Lee JH, Sundaram V, Stein DJ, Kinney SE, Stacey DW, Golubic M. 1997. Reduced expression of schwannomin/merlin in human sporadic meningiomas. Neurosurgery 40:578-587.
15. Lutchman M, Rouleau GA. 1995. The neurofibromatosis type 2 gene product, schwannomin, suppresses growth of NIH 3T3 cells. Cancer Res 55:2270-2274.
16. Magendantz M, Henry MD, Lander A, Solomon F. 1995. Interdomain interactions of radixin in vitro. J Biol Chem 270:25324-25327.
17. Martin M, Roy C, Montcourrier P, Sahuquet A, Mangeat P. 1997. Three determinants in ezrin are responsible for cell extension activity. Mol Biol Cell 8:1543-1557.
18. Martuza RL, Eldridge R. 1988. Neurofibromatosis 2 (bilateral acoustic neurofibromatosis). N Engl J Med 318:685-688.
19. Matsui T, Maeda M, Doi Y, Yonemura S, Amano M, Kaibuchi K, Tsukita S, Tsukita S. 1998. Rho-kinase phosphorylates COOH-terminal threonines of ezrin/radixin/moesin (ERM) proteins and regulates their head-to-tail association. J Cell Biol 104:647-657.
20. McClatchey AI, Saotome I, Mercer K, Crowley D, Gusella JF, Bronson RT, Jacks T. 1998. Mice heterozygous for a mutation at the Nf2 tumor suppressor locus develop a range of highly metastatic tumors. Genes Dev 12:1121-1133.
21. Murthy A, Gonzalez-Agosti C, Cordero E, Pinney D, Candia C, Solomon F, Gusella J, Ramesh V. 1998. NHE-RF, a regulatory cofactor for Na+-H+ exchange, is a common interactor for merlin and ERM (MERM) proteins. J Biol Chem 273:1273-1276.
22. Parry DM, Eldridge R. 1991. Bilateral acoustic neurofibromatosis (NF2): consensus development conference. Bethesda, MD: National Institutes of Health.
23. Pelton PD, Sherman LS, Rizvi TA, Marchionni MA, Wood P, Friedman RA, Ratner N. 1998. Ruffling membrane, stress fiber, cell spreading and proliferation abnormalities in human schwannoma cells. Oncogene 17:2195-2209.
24. Reczek D, Berryman M, Bretscher A. 1997. Identification of EBP50: a PDZ-containing phosphoprotein that associates with members of the ezrin-radixin-moesin family. J Cell Biol 139:169-179.
25. Rouleau GA, Merel P, Lutchman M, Sanson M, Zucman J, Marineau C, Hoang-Xuan K, Demczuk M, Desmaze C, Plougastel B, Pulst SM, Lenoir G, Bijisma E, Fashold R, Dumanski J, de Jong P, Parry D, Eldrige R, Aurias A, Delattre O, Thomas G. 1993. Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2. Nature 363:515-521.
26. Roy C, Martin M, Mangeat P. 1997. A dual involvement of the amino-terminal domain of ezrin in F-and G-actin binding. J Biol Chem 272:20088-20095.
27. Sainio M, Zhao F, Heiska L, Turunen O, den Bakker M, Zwarthoff E, Lutchman M, Rouleau GA, Jaaskelainen J, Vaheri A, Carpen O. 1997. Neurofibromatosis 2 tumor suppressor protein co-localizes with ezrin and CD44 and associates with actin-containing cytoskeleton. J Cell Sci 110:2249-2260.
28. Sainz J, Huynh DP, Figueroa K, Ragge NK, Baser ME, Pulst S-M. 1994. Mutations of the neurofibromatosis type 2 gene and lack of the gene product in vestibular schwannomas. Hum Molec Genet 3:885-891.
29. Scherer SS, Gutmann DH. 1996. Expression of the neurofibromatosis 2 tumor suppressor gene product, merlin, in Schwann cells. J Neurosci Res 46:595-605.
30. Shaw RJ, McClatchey AI, Jacks T. 1998. Regulation of the neurofibromatosis type 2 tumor suppressor protein, merlin, by adhesion and growth arrest stimuli. J Biol Chem 279:7757-7764.
31. Scoles DR, Huynh DP, Morcos PA, Coulsell ER, Robinson NGG, Tamanoi F, Pulst SM. 1998. Neurofibromatosis 2 tumour suppressor schwannomin interacts with betall-spectrin. Nature Genet 18:354-359.
32. Sherman L, Xu H-M, Geist RT, Saporito-Irwin S, Howells N, Ponta H, Herrlich P, Gutmann DH. 1997. Interdomain binding mediates tumor growth suppression by the NF2 gene product. Oncogene 15:2505-2509.
33. Stemmer-Rachamimov AO, Xu L, Gonzalez-Agosti C, Burwick JA, Pinney D, Beauchamp R, Jacoby LB, Gusella JF, Ramesh V, Louis DN. 1997. Universal absence of merlin, but not other ERM family members, in schwannomas. Am J Pathol 151:1649-1654.
34. Tikoo A, Varga M, Ramesh V, Gusella J, Maruta H. 1994. An anti-ras function of neurofibromatosis type 2 gene product (NF2/ merlin). J Biol Chem 269:23387-23390.
35. Trofatter JA, MacCollin MM, Rutter JL, Murrell JR, Duyao MP, Parry DM, Eldridge R, Kley N, Menon AG, Pulaski K, Haase VH, Ambrose CM, Munroe D, Bove C, Haines JL, Martuza RL, MacDonald ME, Seizinger BR, Short MP, Buckler AJ, Gusella JF. 1993. A novel moesin-, ezrin, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell 72: 1-20.
36. Tsukita S, Oishi K, Sato N, Sagara J, Kawai A, Tsukita S. 1994. ERM family members as molecular linkers between the cell surface glycoprotein CD44 and actin-based cytoskeletons. J Cell Biol 126:391-401.
37. Xu H-M, Gutmann DH. 1997. Mutations in the GAP-related domain impair the ability of neurofibromin to associate with microtubules. Brain Res 759:149-152.
38. Xu H-M, Gutmann DH. 1998. Merlin differentially associates with the microtubule and actin cytoskeleton. J Neurosci Res 51:403-415.
39. Yun C-HC, Lamprecht G, Forster DV, Sidor A. 1998. NH3 kinase A regulator protein E3KARP binds the epithelial brush border Na/H exchanger NHE3 and the cytoskeletal protein ezrin. J Biol Chem 273:25856-25863.